FAQ: COVID-19 vaccination
Get answers to frequently asked questions about COVID-19 vaccines and vaccination.
The hype and hope of veterinary cannabis
A range of issues were covered at the first AVMA Cannabis Symposium, from regulatory and toxicological concerns to the drug’s potential as a…
Understand the rules for veterinary compounding, and get resources to support your work with clients whose animals require compounded medications.
policyMEMBERS ONLY UNDER REVIEW
Vaccination of Wolf Hybrids – Position of the AVMA-PLIT
Vaccinating of wolf hybrids has become a topic of concern for veterinarians as a result of their increasing popularity as companion animals.
AVMA, United reach agreement on form for assistance animals
The AVMA, with support from the AVMA PLIT, took action when United Airlines announced a new policy requiring a veterinarian's
Policy spells out reasons for vaccination and following labeling
Recognizing an aversion to vaccination among some members of the public and concerned that some veterinarians are advocating dosing of vaccines that
Veterinarians push against restriction of ketamine
The AVMA and many members have submitted comments emphasizing the importance of access to ketamine ahead of a review by a World Health
AVMA, members push FDA to protect ketamine availability
The AVMA has submitted formal comments asking the U.S. Food and Drug Administration to work to protect veterinarians’ ability to continue using…
Board acts on research, grievance resolution, residues
The AVMA Board of Directors, while meeting Nov. 20-22, 2014, approved a few new policies, rescinded some that were no longer
Ketamine update: WHO committee recommends drug not be placed under international control
The World Health Organization (WHO) Expert Committee on Drug Dependency has once again recommended that ketamine not be placed under international…
Practitioners weigh in on vaccine issues
It was practitioners' turn to have their say about companion animal vaccine issues at a workshop designed to
Groups issue warnings on improper vaccine use
posted May 31, 2011 Practitioners must always walk a fine line when deciding how to tailor vaccine protocols for their patients, but a certain…
AVMA opposes USDA-APHIS vaccine amendment
The AVMA Executive Board narrowly approved a recommendation opposing a government-initiated proposal
Vaccines protect patients by providing a level of resistance to a disease beyond their innate immune status. Each aspect of vaccine efficacy and…
International ketamine rescheduling: can you help us protect veterinary access to this drug?
The following message was sent yesterday to AVMA members who have opted in to receive alerts on animal and public health. To sign up for alerts, visit…
Board debates policy points on medicinal products
Thorny issues surrounding the appropriate use of medicinal products—and how to handle adverse events—prompted discussion during
What is compounding? Dr. Elizabeth Curry-Galvin,assistant directorof the AVMA Division of Scientific Activities, responds:
Extralabel Drug Use and AMDUCA: FAQ
Questions/answers about extra-label (off-label) drug use by veterinarians and the Animal Medicinal Drug Use Clarification Act.
When can a veterinarian import a foreign drug?
NOTE: Please see Oct. 15, 2009, JAVMA News article, "FDA no longer issuing letters for importation for unapproved animal drugs," for…
Reporting adverse vaccine events
Little or no practical safety information exists on vaccine labels or in the literature,
The truth about serum
The anesthesia team is transfusing the patient with plasma believed to contain normal to high protein concentrations.
Ruling could let drug sellers say more
A pharmaceutical salesman’s statements about off-label prescription drug uses were protected under the First Amendment, according to an appellate…
DEA revokes pharmacy's registration
Veterinarians were reminded of the regulations for obtaining compounded controlled substances when the Drug Enforcement Administration
Florida Board of Pharmacy disciplines PetMed Express, Savemax
On April 16, the Florida Department of Health's Board of Pharmacy reached an agreement with PetMed Express Inc.